Lexeo Therapeutics, Inc. (LXEO) Tops Q3 EPS by 51c

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q3 EPS of ($0.33), $0.51 better than the analyst estimate of ($0.84).

For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Aramark adds Florida State, Texas State to NCAA food service portfolio
• Array Technologies holds investor showcase on balance-of-system strategy